212 related articles for article (PubMed ID: 34058209)
21. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
22. Folic acid decorated magnetic nanosponge: An efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging.
Gholibegloo E; Mortezazadeh T; Salehian F; Forootanfar H; Firoozpour L; Foroumadi A; Ramazani A; Khoobi M
J Colloid Interface Sci; 2019 Nov; 556():128-139. PubMed ID: 31437658
[TBL] [Abstract][Full Text] [Related]
23. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
25. Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy.
Liu M; Wang B; Guo C; Hou X; Cheng Z; Chen D
Drug Deliv; 2019 Dec; 26(1):1002-1016. PubMed ID: 31571501
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
27. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
28. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
[TBL] [Abstract][Full Text] [Related]
29. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
30. Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.
Mollarazi E; Jalilian AR; Johari-Daha F; Atyabi F
J Labelled Comp Radiopharm; 2015 Jun; 58(8):327-35. PubMed ID: 26036233
[TBL] [Abstract][Full Text] [Related]
31. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
32. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
Rejinold NS; Muthunarayanan M; Divyarani VV; Sreerekha PR; Chennazhi KP; Nair SV; Tamura H; Jayakumar R
J Colloid Interface Sci; 2011 Aug; 360(1):39-51. PubMed ID: 21549390
[TBL] [Abstract][Full Text] [Related]
33. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.
Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM
Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119
[TBL] [Abstract][Full Text] [Related]
34. A new biodegradable nano cellulose-based drug delivery system for pH-controlled delivery of curcumin.
Anirudhan TS; Manjusha V; Chithra Sekhar V
Int J Biol Macromol; 2021 Jul; 183():2044-2054. PubMed ID: 34097960
[TBL] [Abstract][Full Text] [Related]
35. Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive Nanoparticles.
Rezaei S; Kashanian S; Bahrami Y; Zhaleh H; Cruz LJ
Curr Pharm Biotechnol; 2021; 22(5):622-635. PubMed ID: 32720599
[TBL] [Abstract][Full Text] [Related]
36. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
37. Green synthesis of chitosan/polyacrylic acid/graphitic carbon nitride nanocarrier as a potential pH-sensitive system for curcumin delivery to MCF-7 breast cancer cells.
Abdouss H; Pourmadadi M; Zahedi P; Abdouss M; Yazdian F; Rahdar A; Díez-Pascual AM
Int J Biol Macromol; 2023 Jul; 242(Pt 3):125134. PubMed ID: 37257532
[TBL] [Abstract][Full Text] [Related]
38. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
39. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
40. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]